MX2010008718A - Piperidinas sustituidas como inhibidores de renina. - Google Patents

Piperidinas sustituidas como inhibidores de renina.

Info

Publication number
MX2010008718A
MX2010008718A MX2010008718A MX2010008718A MX2010008718A MX 2010008718 A MX2010008718 A MX 2010008718A MX 2010008718 A MX2010008718 A MX 2010008718A MX 2010008718 A MX2010008718 A MX 2010008718A MX 2010008718 A MX2010008718 A MX 2010008718A
Authority
MX
Mexico
Prior art keywords
renin inhibitors
substituted piperidines
compounds
salts
piperidines
Prior art date
Application number
MX2010008718A
Other languages
English (en)
Inventor
Peter Herold
Robert Mah
Vicenzo Tschinke
Dirk Behnke
Stjepan Jelakovic
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX2010008718A publication Critical patent/MX2010008718A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

La presente invención se refiere a compuestos de la fórmula general (I) y sales de los mismos, preferentemente las sales farmacéuticamente aceptables de los mismos, en donde R tiene el significado explicado en la descripción, a un proceso para su preparación y al uso de estos compuestos como medicinas especialmente como inhibidores de renina.
MX2010008718A 2008-02-08 2009-02-06 Piperidinas sustituidas como inhibidores de renina. MX2010008718A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08101428 2008-02-08
PCT/EP2009/051350 WO2009098276A1 (en) 2008-02-08 2009-02-06 Substituted piperidines as renin inhibitors

Publications (1)

Publication Number Publication Date
MX2010008718A true MX2010008718A (es) 2010-09-24

Family

ID=40020274

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010008718A MX2010008718A (es) 2008-02-08 2009-02-06 Piperidinas sustituidas como inhibidores de renina.

Country Status (11)

Country Link
US (1) US8022069B2 (es)
EP (1) EP2250166A1 (es)
JP (1) JP2011511039A (es)
KR (1) KR20100131427A (es)
CN (1) CN101939318A (es)
AU (1) AU2009211378A1 (es)
BR (1) BRPI0907933A2 (es)
CA (1) CA2714350A1 (es)
EA (1) EA201001239A1 (es)
MX (1) MX2010008718A (es)
WO (1) WO2009098276A1 (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200613274A (en) 2004-07-09 2006-05-01 Speedel Experimenta Ag Organic compounds
JP2008535825A (ja) 2005-03-31 2008-09-04 シュペーデル・エクスペリメンタ・アーゲー レニン阻害剤としての3,4,5−置換ピペリジン
TW200833687A (en) 2005-03-31 2008-08-16 Speedel Experimenta Ag Substituted piperidines

Also Published As

Publication number Publication date
AU2009211378A1 (en) 2009-08-13
CA2714350A1 (en) 2009-08-13
EP2250166A1 (en) 2010-11-17
JP2011511039A (ja) 2011-04-07
US20100331322A1 (en) 2010-12-30
BRPI0907933A2 (pt) 2015-07-28
KR20100131427A (ko) 2010-12-15
EA201001239A1 (ru) 2011-04-29
US8022069B2 (en) 2011-09-20
WO2009098276A1 (en) 2009-08-13
CN101939318A (zh) 2011-01-05

Similar Documents

Publication Publication Date Title
MY149731A (en) Compounds
UA108926C2 (ru) LibreOffice? [2,3-D] +" +" !+
TN2012000152A1 (en) Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes
GEP20125491B (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
TN2012000248A1 (en) Novel spiropiperidine compounds
JO3577B1 (ar) صيغ صيدلانية تشمل مشتقات 1-(بيتا-d- غلوكوبيرانوسيل) -2-ثينيل ميثيل بنزين كمثبطات sglt
MX2012004311A (es) Derivados de ciclohexano spiro condensados como inhibidores de lipasa sensible a hormonas (hsl) utiles en el tratamiento de diabetes.
NO20083708L (no) 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
UA99787C2 (en) Lactams as beta secretase inhibitors
UA101091C2 (ru) Способ синтеза ивабрадина и его аддитивных солей с фармацевтически приемлемой кислотой
MY146084A (en) Benzyl amines, a process for their production and their use as anti-inflammatory agents
WO2010091104A8 (en) Glucosylceramide synthase inhibitors
WO2009126861A3 (en) Triazolopyridine compounds useful as dgat1 inhibitors
MY161749A (en) Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use
WO2009094560A3 (en) Thienopyranones as kinase inhibitors
WO2008087654A3 (en) PIPERIDINES AS INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1
IN2012DN01292A (es)
UA104420C2 (uk) Застосування похідних глутарової кислоти або їх фармацевтично прийнятних солей як протиаритмічних засобів
WO2011047055A8 (en) Novel mek inhibitors, useful in the treatment of diseases
MX2010004235A (es) Piperidinas tri-sustituidas.
MX2010004505A (es) Piperidinas 4,4-disustituidas.
MX2010001075A (es) Derivados de n-piperidin-4-ilmetil-amida y su uso como inhibidores de recaptacion del neurotransmisor de monoamina.
MX2010006218A (es) Compuestos organicos.
MX2010004759A (es) Piperidinas 4,4-disustituidas como inhibidoras de renina.
WO2009074674A3 (en) Trisubstituted piperidines as renin inhibitors

Legal Events

Date Code Title Description
FA Abandonment or withdrawal